DXCM: Dexcom Inc Company Profile & Statistics

About

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

Info & Links

CEO

Kevin R. Sayer

Headquarters

6340 SEQUENCE DRIVE
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

9,600

Dexcom Inc Statistics

Valuation Measures

Market Capitalization²

31.27B

Enterprise Value

33.09B

Enterprise Value/EBITDA(ttm)

39.37

Price to Earnings Ratio(ttm)

44.60

Price to Sales(ttm)

7.49

Price to Book(mrq)

14.97

Price to Cash(ytd)

36.64

Profitability

Gross Margin(ttm)

61.65%

Operating Margin(ttm)

17.33%

Profit Margin(ttm)

17.12%

Return on Equity(ttm)

31.40%

Return on Invested Capital(ttm)

14.81%

Return on Assets(ttm)

10.58%

Income Statement

Revenue(ttm)

3.95B

Revenue Per Share(ttm)

10.12

Gross Profit(ttm)

2.44B

EBITDA(ttm)³

840.40M

Net Income Available to Common(ttm)

680.80M

Diluted EPS(ttm)

1.67

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

-32.29%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

390.60M

Dividend Yield

0.00%

Float⁴

389.42M

% Held by Insiders

0.30%

% Held by Institutions

97.75%

Balance Sheet

Total Cash(mrq)

2.49B

Total Cash Per Share(mrq)

6.38

Total Debt(mrq)

2.44B

Total Debt/Equity(mrq)

123.27%

Current Ratio(mrq)

2.46%

Quick Ratio(mrq)

2.12%

Book Value Per Share(mrq)

5.07

Cash Flow

Operating Cash Flow Per Share(ytd)

1.68

Free Cash Flow(ytd)

453.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

DXCM

Dexcom Inc

Dexcom Inc Profile